Skip Nav Destination
.Getting the Most from Minimal Residual Disease|
November 5, 2020
Advances in Mass Spectrometry for Myeloma Minimal Residual Disease
Katie Thoren
Katie Thoren
1Memorial Sloan Kettering Cancer Center, New York, NY
Search for other works by this author on:
Blood (2020) 136 (Supplement 1): SCI1.
Citation
Katie Thoren; Advances in Mass Spectrometry for Myeloma Minimal Residual Disease. Blood 2020; 136 (Supplement 1): SCI1. doi: https://doi.org/10.1182/blood-2020-133038
Download citation file:
November 5 2020
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal